University Hospitals of North Midlands has secured £250,000 from NIHR to run the ICE trial, a two‑year feasibility study testing a novel dye method to improve surgical outcomes in endometriosis.
With numerous side effects and fluctuating reliability, contraception has a long way to go in order to provide the healthcare that people around the world need.
Tess Player, VP, Global Head of Expert and Influence Marketing, GSK Consumer Healthcare, discusses how low public understanding of oral health is symptomatic of the need for better everyday health education.
Pregnant individuals who contract COVID-19 face a higher risk of having a preterm birth, according to researchers at The University of California, San Francisco (UCSF).
A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.
Google searches for infertility relating to COVID-19 vaccines increased by 34,900% after a pair of physicians submitted a petition questioning their safety.
Maternity safety minister Nadine Dorries has announced £2.45 million in funding for the NHS to improve the safety of women and babies during childbirth.
Associate Professor Ken Tachibana, discloses how prenatal ambient fine particle exposure disrupts DNA methylation and subsequent gene expression in the foetal development stage.
Professor Arri Coomarasamy, Director of Tommy’s National Centre for Miscarriage Research, turns the spotlight on a common but historically overlooked issue, as ground-breaking new studies lead to calls for UK-wide policy change.
